Gilead Sciences
GILD
#104
Rank
A$261.84 B
Marketcap
A$211.17
Share price
1.82%
Change (1 day)
19.07%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$54.09 Billion

According to Gilead Sciences's latest financial reports the company's total liabilities are A$54.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$54.35 B-14.95%
2024-12-31A$63.90 B10.57%
2023-12-31A$57.79 B-6.27%
2022-12-31A$61.66 B-4.66%
2021-12-31A$64.67 B-0.91%
2020-12-31A$65.26 B17.24%
2019-12-31A$55.67 B-6.94%
2018-12-31A$59.81 B-6.19%
2017-12-31A$63.76 B22.2%
2016-12-31A$52.18 B16.6%
2015-12-31A$44.75 B94.36%
2014-12-31A$23.02 B89.58%
2013-12-31A$12.14 B7.92%
2012-12-31A$11.25 B10.58%
2011-12-31A$10.17 B88.97%
2010-12-31A$5.38 B51.5%
2009-12-31A$3.55 B1.49%
2008-12-31A$3.50 B37.05%
2007-12-31A$2.55 B-9.13%
2006-12-31A$2.81 B178.66%
2005-12-31A$1.00 B173.98%
2004-12-31A$0.36 B-50.37%
2003-12-31A$0.74 B-41.66%
2002-12-31A$1.27 B89.67%
2001-12-31A$0.67 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$166.93 B 208.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$166.28 B 207.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$202.76 B 274.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$155.88 B 188.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$120.72 B 123.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$19.03 B-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$5.58 B-89.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$10.31 B-80.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$126.28 B 133.45%๐Ÿ‡บ๐Ÿ‡ธ USA